GeneDx Holdings Corp.WGS

$59.01+2.59 (+4.59%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$2B
Small-cap
-16%
2020 — today
10-Year Price
-84%
2020 — today
52-Week Range
$34.51$167.52
Current $59.01· 18%

GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.

Valuation in context

P/E ratio
-22.2
N/A
Not meaningful — company is unprofitable
P/B ratio
6.8
Above average
Pricier than usual over the last 10 years
FCF Yield
-1.7%
Above average
Above the 10-year average
Free · No credit card needed

Get alerted when WGS is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.